Heptares Co-Founder Resigns as VP and CSO of Parent Company Sosei Post author:Sam Post published:January 18, 2018 Post category:BioPharma Dr. Marshall will leave Sosei at the end of February 2018. Source: BioSpace You Might Also Like Medidata Solutions, Inc. Release: Chugai Deploys Ravex To Modernize Post-Marketing Surveillance June 29, 2017 AI Takes Off in Biotech, Creating Demand for High Paying Jobs of $500K Plus November 6, 2017 Flushed With Cash, Shanghai Pharma Hunts for M&A in the U.S. and Europe January 23, 2018
Medidata Solutions, Inc. Release: Chugai Deploys Ravex To Modernize Post-Marketing Surveillance June 29, 2017
